Annular reduction using the Cardioband system to treat tricuspid regurgitation
This video is supported by Edwards Lifesciences
Summary
Tricuspid regurgitation is notoriously hard to manage, with limited medical treatment options. What are the therapeutic options available and how can the risks to patients of treatment be reduced? Patrizio Lancellotti (Belgium) talks to Stephan Baldus (Germany) and Claudius Jacobshagen (Germany) about the Cardioband tricuspid valve reconstruction system, a promising interventional therapy that can be used to reduce the annular size without the need for risky open heart surgery. Find out about the 1-year data from the TRI-REPAIR study and which patients might benefit from this technology in the future…
This interview supported by Edwards Lifesciences was filmed at EuroPCR 2019: see more videos here…